Pipeline
The Science
About us
Investors
News

Hit enter to search or ESC to close

Dr David Stamler Biotech Showcase Presentation

January 8, 2018 Kerry Rowe

Prana Biotechnology JPM investor presentation_updated

Post navigation

Prana meeting with investors at world’s largest healthcare conference in San Francisco

PBT434 poster presented at the 6th International Multiple System Atrophy Conference

Related Posts

Alterity Therapeutics to Participate in Two Upcoming Investor Conferences

November 22, 2021January 6, 2022

Prana Announces A$6.0 Million Capital Raising

July 17, 2013

XBRL 30 June 2021 filed with the SEC

September 3, 2021October 29, 2021

Recent Posts

Alterity Therapeutics to Participate in the Benchmark Company Healthcare House Call Conference
Appendix 4C – Q3 FY22 Quarterly Cash Flow Report
Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in the United Kingdom
Alterity Therapeutics Announces Presentation of bioMUSE Data at the American Academy of Neurology (AAN) Annual Meeting
Alterity Therapeutics to Participate in the Sachs Associates 5th Annual Neuroscience Innovation Forum

Recent Comments

Archives

Archives

Categories

ASX Announcements
Investor Announcement

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065